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A B S T R A C T
Objective: to examine the diagnostic accuracy of traditional ‘red ﬂags’ for necrotizing fasciitis (NF) on
history and physical examination.
Methods: retrospective study of all cases of NF admitted to a large tertiary care hospital between January
1 2004 and December 31 2013, each matched to two control patients with cellulitis. We determined the
diagnostic test characteristics of clinical features for distinguishing NF from cellulitis, with emphasis on
positive (LR+) and negative (LR-) likelihood ratios.
Results: There were no individual ﬁndings with sufﬁcient sensitivity to rule out NF (sensitivity  85% and
LR-  0.5 for all ﬁndings). The clinical features that most signiﬁcantly increased the odds of NF were
recent surgery (LR+ 7.0) pain-out-of-proportion (LR+ 4.5), diarrhea (LR+ 6.0), hypotension (LR+ 8.0),
altered mental status (LR+ 3.3), erythema progressing beyond margins (LR+3.1), ﬂuctuance (LR+ 5.0),
hemorrhagic bullae (LR+ 8.0) and skin necrosis (LR+ 30.0). Each individual ﬁnding conferred low
sensitivity, but absence of all nine ruled out NF (LR- 0.04). The presence of >=3 ﬁndings ruled in NF (LR+
undeﬁned).
Conclusions: When considered together, the traditional ‘red ﬂags’ for NF may be sufﬁcient to rule in or
rule out the diagnosis. If future prospective studies validate these ﬁndings, there will be a potential
opportunity to expedite NF diagnosis and improve patient outcomes.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Background
Cellulitis is among the most common bacterial infections,1 and
rates have increased over time to greater than 4 cases per
100 people/year in the United States.2 Necrotizing fasciitis (NF) is a
much more severe form of soft tissue infection, with mortality
rates exceeding 30%; fortunately it is also much rarer than
cellulitis, with an incidence of only 4 cases per 100,000 people/year
in the United States.3
It is challenging to distinguish the once-in-awhile NF patients,
from the every-day cellulitis patients presenting to the emergency
department. Prompt recognition of NF is essential, though, becauseAbbreviations: LR+, positive likelihood ratio; LR-, negative likelihood ratio; NF,
necrotizing fasciitis; NPV, negative predictive value; PPV, positive predictive value;
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).it requires different antimicrobial management (including poly-
microbial coverage for Type I NF infections or clindamycin
adjunctive treatment for Group A Streptococcal Type II NF
infections), but more importantly because it requires emergent
surgical debridement for cure.4 The majority of cases of NF are
initially misdiagnosed,5 and delays in NF diagnosis are strongly
associated with increased mortality.6–9
The deﬁnitive diagnostic test for NF is surgical exploration and
biopsy; due to invasiveness, it should be reserved for patients with
a meaningful probability of having this infection. Therefore, it
would be helpful to have non-invasive clinical methods that aid in
ruling in or ruling out NF. There are several symptoms and signs
that are commonly considered to be ‘red ﬂags’ for NF, such as pain
out of proportion, hypotension and hemorrhagic bullae.3,10 The
Infectious Diseases Society of America (IDSA) guidelines for
management of skin and soft tissue infection encourage assess-
ment for these features on history and physical examination, but
cite no references to support their diagnostic utility.4 This is
because prior studies of diagnostic accuracy in the evaluation of NF
have focused only on the results of baseline blood work 11,12 or
radiologic imaging.13ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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characteristics of common elements of the history and physical
examination in identifying NF versus cellulitis.
2. Methods
2.1. General Study Design and Setting
We performed a retrospective case control study at Sunnybrook
Health Science Centre (SHSC), to examine the diagnostic value of
history, physical examination and laboratory ﬁndings among
patients with NF or cellulitis admitted between January 1 2004 and
December 31 2013. SHSC is a tertiary care, University-afﬁliated
hospital with 824 acute care beds, located in Toronto, Ontario,
Canada. Ethics approval was obtained from the SHSC Research
Ethics Board.
2.2. Identifying Cases with Necrotizing Fasciitis
We screened for cases of NF using a computer-generated search
through the medical records department for all patients diagnosed
with NF (ICD-10-CM Diagnosis Codes M72.60-M72.69). Additional
cases were detected by screening the SHSC microbiology
laboratory database for patients with Group A Streptococcus
isolated from a sterile site specimen, such as tissue biopsy or blood
culture, as well as operating room databases for patients
undergoing emergent wound debridement. The charts of all these
patients with possible NF were screened to determine if they met
our reference standard criteria for NF (see below). We also
excluded patients transferred to SHSC from other health facilities,
as the chart would not be expected to reliably contain full
descriptions of initial history, physical examination and laboratory
ﬁndings.
2.3. Identifying Control Patients with Cellulitis
We screened for candidate control group patients using a
computer-generated search through the medical records depart-
ment for all patients diagnosed with cellulitis (ICD-10-CM
Diagnosis Codes: L03.00-L03.39, L03.8, L03.9). Since we expected
the number of patients with cellulitis to far outnumber those with
NF, we randomly selected two patients with cellulitis from the
same year of admission as each NF case. The use of two rather than
one control per case increased statistical power – but there are
diminishing returns in statistical power with use of further
numbers of controls per case.14
2.4. Reference Standard for Determining Necrotizing Fasciitis
To be included as a conﬁrmed case of NF, the patient
presentation had to meet at least one of the following criteria:
(i) gross evidence of necrotic fascia during surgical exploration, (ii)
positive bacterial culture from a fascia biopsy, and/or (iii)
pathologic conﬁrmation of necrosis on a fascia biopsy.
2.5. Potential Diagnostic Predictors of Necrotizing Fasciitis
After careful review of the literature, a data collection form
was generated to capture demographic features, comorbidities
and potential diagnostic predictors of NF on history, physical
examination and laboratory testing. Demographic, history and
physical examination features of interest were recorded as present
if they were mentioned in any of the emergency room notes, initial
nurses’ notes, or initial doctors’ consultation notes. If these features
were not mentioned in any of these notes, they were recorded as
absent. Given the retrospective study design, we did not requirequantitative thresholds for comorbidity deﬁnitions (such as body
mass-index for obesity, or recent time of malignancy diagnoses)
because these may not be reliably recorded. Historical features of
interest included subjective fever, chills, shortness of breath, skin
swelling, pain, pain out of proportion, skin anesthesia, surgery
within the preceding 90 days, nausea/vomiting and diarrhea. For
vital signs, we used the ﬁrst available measurements on
presentation. We dichotomized all continuous variables based
on routinely accepted thresholds, such as a lower limit of systolic
blood pressure of 90 mmHg, such that test characteristics could be
easily calculated based on the presence or absence of each
abnormality. Other physical examination features of interest,
included erythema, erythema progressing beyond marked mar-
gins, tenderness, swelling, local warmth, ﬂuid-ﬁlled vesicles,
hemorrhagic bullae, skin ﬂuctuance, skin induration, skin anaes-
thesia, crepitus, necrosis, ischemia, cyanosis, purulence and altered
level of consciousness. We collected data on all laboratory tests
included in the Laboratory Risk Indicator for Necrotizing Fasciitis
(LRINEC) scoring system for NF,12 as well as a select number of
other potentially important predictors including the international
normalized ratio, lactate, creatine kinase and bicarbonate. We
recorded the ﬁrst laboratory values on arrival to hospital. Data on
the use of radiologic tests (x-ray, computed tomography scan,
magnetic resonance imaging) and the presence of abnormalities on
these tests were also recorded.
2.6. Statistical Analysis
We compared baseline patient characteristics among NF cases
and cellulitis controls using chi-square test for categorical
variables, and Wilcoxon rank sum test for continuous variables.
As per standard deﬁnitions, sensitivity was calculated as the
proportion of NF cases with a given ﬁnding, while speciﬁcity was
calculated as the proportion of cellulitis controls without that
given ﬁnding. Positive predictive value (PPV) was calculated as the
proportion of patients with a given positive ﬁnding who had NF;
negative predictive value (NPV) was calculated as the proportion
without a given ﬁnding who had cellulitis. We also measured
likelihood ratios. The positive likelihood ratio (LR+) is deﬁned as
sensitivity/(1-speciﬁcity) and expresses the increase in the odds of
having NF when the ﬁnding is positive. The negative likelihood
ratio (LR-) is deﬁned as (1-sensitivity)/speciﬁcity and expresses the
decrease in the odds of having NF when the ﬁnding is negative.
We put low emphasis on the results of PPV and NPV, since we
arbitrarily set the prevalence of NF at 1/3 in our study design
(because we included two controls for every one case) but in
regular clinical practice the prevalence of NF would be much lower
(with many more cellulitis cases for each NF case). In our study, the
true NPV will be underestimated and PPV will be overestimated.
Therefore, we emphasized the LR+ and LR- as the most important
diagnostic test characteristics, because these are intrinsic char-
acteristics of the diagnostic test and independent of population
disease prevalence.
In our primary analysis, we separately determined the
diagnostic test characteristics of each individual ﬁnding on history,
physical examination and laboratory testing. In an exploratory
secondary analysis, we developed an additive risk score combining
the characteristics with the highest LR+ for NF. We generated a
Receiver Operating Characteristics Curve, based on tradeoffs in
sensitivity and speciﬁcity for each possible risk score in our index.
The risk score was intended to be exploratory, because the
available sample size of patients with NF was not anticipated to be
sufﬁcient to provide derivation and validation subsets, or to allow
for multivariable modeling to enable weighted scoring. In the
absence of multivariable modeling we weighted each predictive
clinical characteristic equally (1 point each), in order to develop a
K.A. Alayed et al. / International Journal of Infectious Diseases 36 (2015) 15–20 17parsimonious risk score with a memorable acronym. All analyses
were performed in Microsoft excel, and SAS version 9.3 (Cary, NC).
2.7. Sample Size Calculation
At an expected sample size of 100 patients with NF, we
calculated that we would have 80% power to detect a 20% absolute
difference between a given predictor variable among patients with
and without NF (alpha 0.05).
3. Results
3.1. General Characteristics of NF and Cellulitis Patients
After screening all potential NF cases from our medical records
department, operating room and microbiology database, we
identiﬁed 40 patients who met our reference standard criteria
for NF – 36 (90%) had gross evidence of NF on surgical inspection,
28 (70%) had documentation of NF on a pathology specimen, and
39 (98%) had a positive bacterial culture from a fascia biopsy
specimen. We randomly selected two patients with cellulitis as
controls from the same year of admission as each NF case,
generating a total of 40 case patients with NF and 80 control
patients with cellulitis. NF occurred more frequently in younger
populations than cellulitis, but there was no difference in gender
distribution (Table 1). Having had surgery at the site of infection
within the last 90 days was signiﬁcantly more common among NF
cases than cellulitis controls (35% vs 5%, p<0.001). As expected,
length of stay in hospital, mortality and need for ICU admission
were all much higher in the NF group (Table 1).
3.2. Microbiology of NF and Cellulitis
Positive cultures were more common among NF cases than
cellulitis controls (95% vs 24%, p<0.001). Among the patients withTable 1







Age  50 years 27(67.5) 68(85) 0.03
Female sex 21(52.5) 39(48.75) 0.70
Alcohol abuse 3(7.5) 5(6.25) 0.80
Coronary artery disease 7(17.5) 21(26.25) 0.29
Cirrhosis 1(2.5) 3(3.75) 0.72
Congestive heart failure 5(12.5) 14(17.5) 0.48
Chronic obstructive pulmonary disease 1(2.5) 10(12.5) 0.07
Chronic renal insufﬁciency 3(7.5) 11(13.75) 0.31
Diabetes mellitus 11(27.5) 22(27.5) >0.99
Hepatitis B 0(0) 1(1.25) 0.48
Hepatitis C 1(2.5) 1(1.25) 0.61
Hypertension 21(52.5) 40(50) 0.80
Immunosuppression 2(5) 7(8.75) 0.46
Injection drug abuse 3(7.5) 2(2.5) 0.20
Malignancy 13(32.5) 23(28.75) 0.67
Obesity 5(12.5) 11(13.75) 0.85
Peripheral vascular disease 2(5) 4(5) >0.99
Rheumatoid arthritis 0(0) 5(6.25) 0.11
Smoking 8(20) 14(17.5) 0.74
Cerebrovascular disease 4(10) 6(7.5) 0.64
Surgery at site of disease within 90 days 14(35) 4(5) <0.001
Venous stasis 1(2.5) 12(15) 0.04
Length of stay in days [Median (IQR)] 13 (6.5-38.5) 5 (4-10) <0.001
Survival to hospital discharge 27(67.5) 78(97.5) <0.001
Required intensive care 18(45) 3(4.0) <0.001
Data are shown as No. (%) unless otherwise indicated.
Human immunodeﬁciency virus infectious, systemic lupus erythematosis, corti-
costeroid use, and spinal cord injury were also evaluated, but were present in <
1 patient.culture-positive NF, nearly two-thirds (60.5%) had type I (poly-
microbial) NF. The most common microorganisms isolated from
patients with necrotizing fasciitis included Enterococcus spp.
(8 patients), E. coli (7), Group A streptococcus (6), coagulase
negative staphylococci (5), Staphylococcus aureus (4), Pseudomonas
spp. (3), Enterobacter spp. (3), Candida spp. (3), Streptococcus
viridians group (3), Group B Streptococcus (2), other aerobes (5),
other anaerobes (7). The majority of necrotizing fasciitis isolates
were from sterile site cultures (45/58, 78%). The most common
organisms isolated from patients with cellulitis were Staphylococ-
cus aureus (10 patients), Group A Streptococcus (6), and Group B
Streptococcus, Moraxella spp., Pasteurella spp, Actinomyces spp., and
coagulase negative staphylococci (1 each). However, only a
minority of cellulitis isolates were from sterile site cultures (2/
18, 11%).
3.3. Accuracy of Historical Findings in Diagnosing Necrotizing Fasciitis
The most common presenting symptom was pain (sensitivity
only 75%), and there were no items on history with a LR- below
0.5. The element in history that most increased the odds of having
NF was surgery at the site of infection within the last 90 days (LR+
7.0). We found that pain out of proportion also increased the odds
of NF (LR+ 4.57) (Table 2).
3.4. Accuracy of Physical Examination Findings in Diagnosing
Necrotizing Fasciitis
The most common physical exam ﬁnding was erythema
(sensitivity only 85%), and there were no items on physical
examination with a LR- below 0.5 (Table 2). Regarding the
diagnostic accuracy of vital signs and other aspects of the physical
examination, hypotension (systolic blood pressure < 90 mmHg),
erythema progressive beyond margins drawn in the emergency
department, hemorrhagic bullae and skin necrosis were associated
with LR+ of 8.0, 3.09, 8.0 and 30.0, respectively (Table 2).
3.5. Accuracy of Basic Laboratory Findings in Diagnosing Necrotizing
Fasciitis
The only laboratory result with a signiﬁcant LR+ was the
presence of severe leukocytosis (WBC >25 mm3) (LR+ 3.0). Only
16 of the 120 patients enrolled in the study had their C-reactive
protein level checked, which precluded validation of the LRINEC
score in our study population (Table 3).
3.6. Use of Diagnostic Imaging to Detect Necrotizing Fasciitis
Overall, a high proportion of suspected and proven cases of NF
had radiologic imaging prior to any surgical intervention. In the NF
group, 26 (65%) patients underwent a computed tomography scan,
12 (30%) had an x-ray, four (10%) had an ultrasound and two (5%)
underwent magnetic resonance imaging. The presence of gas and
ﬂuid collections increased the likelihood of having NF among the
subset of patients that underwent imaging (LR+ 6.04 and 4.23,
respectively), while the absence of gas across tissue planes only
marginally decreased the likelihood of NF (LR- 0.46).
3.7. ‘‘PHONES For Surgical Doctor’’: A Risk Prediction Score for NF
In an exploratory analysis, we combined the individual ﬁndings
with the strongest LR+ values for NF into an additive risk score,
entitled ‘‘PHONES For Surgical Doctor’’. One point was awarded for
each of the following ﬁndings, totaling to a maximum of nine
points: P-pressure (systolic blood pressure <90 mmHg), H-
hemorrhagic bullae, O-Out of proportion pain, N-Necrotic skin,
Table 2
Diagnostic Accuracy of History and Physical Examination Findings in Distinguishing Necrotizing Fasciitis from Cellulitis
History Sensitivity Speciﬁcity PPV NPV LR+ LR-
Subjective fever 0.45 0.68 0.41 0.71 1.38 0.81
Chills 0.33 0.66 0.33 0.66 0.96 1.01
Shortness of breath 0.3 0.85 0.5 0.708 2.0 0.82
Skin swelling 0.6 0.08 0.27 0.30 0.66 4.57
Pain 0.75 0.1 0.29 0.44 0.83 2.5
Pain out of proportion 0.4 0.91 0.7 0.75 4.57 0.66
Skin anesthesia 0.0 0.96 0.0 0.66 0.0 1.03
Surgery within 90 days 0.35 0.95 0.78 0.75 7.0 0.68
Nausea and vomiting 0.33 0.86 0.54 0.72 2.36 0.78
Diarrhea 0.075 0.98 0.75 0.68 6.0 0.93
Physical examination Sensitivity Speciﬁcity PPV NPV LR+ LR-
Erythema 0.85 0.05 0.31 0.4 0.89 3
Erythema progressive beyond margins 0.43 0.86 0.61 0.75 3.09 0.67
Tenderness 0.73 0.16 0.3 0.54 0.87 1.69
Swelling 0.7 0.05 0.27 0.25 0.74 6.0
Local warmth 0.35 0.28 0.19 0.46 0.48 2.36
Fluid-ﬁlled vesicles (ulcers, blisters, bullae) 0.3 0.75 0.38 0.68 1.2 0.93
Skin ﬂuctuance 0.13 0.98 0.71 0.69 5.0 0.9
Skin induration 0.1 0.91 0.36 0.67 1.14 0.99
Hemorrhagic bullae 0.1 0.99 0.8 0.69 8.0 0.91
Skin anesthesia 0.0 0.98 0.0 0.66 0.0 1.01
Crepitus 0.13 1.0 1.0 0.7 N/A 0.88
Necrosis 0.38 0.99 0.94 0.76 30.0 0.63
Ischemia 0.0 1.0 N/A 0.66 N/A 1.0
Cyanosis 0.15 1.0 1.0 0.7 N/A 0.85
Purulence 0.4 0.85 0.57 0.74 2.67 0.71
Altered LOC 0.25 0.93 0.63 0.71 3.33 0.81
LOC = level of consciousness | LR+ = positive likelihood ratio | LR- = negative likelihood ratio | NPV = negative predictive value | PPV = positive predictive value
K.A. Alayed et al. / International Journal of Infectious Diseases 36 (2015) 15–2018E-Erythema progressing beyond margins, S-Sensorium altered,
For-Fluctuance, and Surgical-surgical procedure within preceding
90 days, Doctor - Diarrhea. A score of zero substantially lowered
the probability of NF (sensitivity 97.5%, LR- 0.040), while a score of
three or above substantially increased the probability of NF
(speciﬁcity 100%, LR+ undeﬁned). A receiver operating character-
istics curve was generated based on the tradeoffs of sensitivity andTable 3
Diagnostic Accuracy of Vital Signs and Basic Laboratory Test Results in Distinguishing 
Vitals Sensitivity Speciﬁcity 
Blood pressure
sBP<90 mmHg 0.2 0.98 
dBP<60 mmHg 0.5 0.91 
Heart rate
>100 BPM 0.53 0.65 
Respiratory rate 0.49 0.79 
>20 RPM
Oxygen saturation
<95% 0.16 0.91 
Temperature
>38.0 8C 0.3 0.76 
Laboratory ﬁndings Sensitivity Speciﬁcity 
C-reactive protein*
150 mg/L 0.5 0.75 
Total WBC
<4mm3 0.13 0.98 
>15mm3 0.35 0.74 
>25 mm3 0.08 0.98 
Hemoglobin
<135 g/L 0.55 0.36 
<110 g/L 0.3 0.85 
Sodium
<135 mmol/L 0.4 0.77 
Creatinine
>141 mmol/L 0.33 0.84 
Glucose
>10 mmol/L 0.26 0.91 
BPM = beats per minute | LR = likelihood ratio | NPV = negative predictive value | PPV = p
* in contrast to the other laboratory tests which were collected in all patients as par
patientsspeciﬁcity at increasing ‘‘PHONES For Surgical Doctor’’ scores
(Figure 1).
4. Discussion
This study provides the ﬁrst rigorous conﬁrmation of the
diagnostic accuracy of many of the clinical ﬁndings traditionallyNecrotizing Fasciitis from Cellulitis
PPV NPV Positive LR Negative LR
0.8 0.71 8 0.82
0.74 0.78 5.71 0.55
0.43 0.73 1.5 0.73
0.53 0.76 2.29 0.65
0.46 0.7 1.8 0.92
0.4 0.69 1.3 0.9
PPV NPV Positive LR Negative LR
0.4 0.82 2 0.67
0.71 0.69 5 0.89
0.4 0.69 1.3 0.88
0.6 0.68 3 0.95
0.3 0.62 0.86 1.24
0.5 0.71 2 0.82
0.47 0.72 1.76 0.78
0.5 0.71 1.98 0.81
0.59 0.71 2.78 0.81
ositive predictive value | RPM = respirations per minute | WBC = white blood cell
t of routine care, C-reactive protein measurements were only available for 16/120
Figure 1. Receiver Operating Characteristic Curve for the ‘‘PHONES For Surgical Doctor’’ Risk Score for Necrotizing Fasciitis. In this risk score, 1 point was assigned for
each of 9 clinical features (see box). A score of 0 substantially lowered the probability of necrotizing fasciitis (sensitivity 97.5%). A score of 3 or higher substantially increased
the probability of necrotizing fasciitis (speciﬁcity 100%).
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items are pain out of proportion, diarrhea, and surgery in the
preceding 90 days; on physical examination, the most important
signs are hypotension, altered mental status, erythema progressing
beyond marked margins, skin ﬂuctuance, hemorrhagic bullae and
skin necrosis. The presence of three or more of these ﬁndings
virtually ruled in NF (speciﬁcity 100%, LR+ undeﬁned). Although,
the absence of any individual ﬁnding was of little diagnostic utility,
the absence of all of these ﬁndings virtually ruled out NF
(sensitivity 97.5%, LR- 0.04).
The high LR+ associated with these clinical ﬁndings can be
understood on the basis of the pathogenesis of NF, which involves
rapid, uncontrolled bacterial proliferation and horizontal spread
along the superﬁcial fascial layer.10 The high prevalence of
preceding surgery in this population is not surprising, as deep
surgical incisions offer a direct portal of entry to the fascia,15
whereas most cellulitis cases result from more superﬁcial, often
imperceptible portals of entry.16 The report of pain out of
proportion can be understood on the basis of the initial spread
of the infections in the fascial layer, with minimal initial
involvement of the overlying skin and subcutaneous tissues. The
greater severity of NF compared to cellulitis, and the potential
association with Group A Streptococcal toxic shock syndrome, can
explain the increased prevalence of hypotension and altered
mental status as features of the systemic inﬂammatory response.17
Although cellulitis, by deﬁnition, involves rapidly spreading
inﬂammation of the skin and subcutaneous tissues,16 the tempo
of NF is faster; therefore, erythema is more likely to spread beyond
initial marked margins. As NF progresses, the occlusion of
perforating vessels is likely responsible for skin ﬂuctuance,
hemorrhagic bullae and skin necrosis.10,18,19 The lack of sensitivity
for any of these individual ﬁndings may relate to the origin of NF in
the fascial layer, where hidden beneath the skin and subcutaneoustissues, substantial progression may take place before any
particular symptom or sign becomes evident.
Previous literature assessing the diagnostic accuracy of NF tests
has focused on laboratory and radiology results rather than history
and physical examination ﬁndings. The most intriguing prior study
involved the combination of C-reactive protein, total white blood
cell count, hemoglobin, sodium, creatinine and glucose measure-
ments into the LRINEC score.12 A LRINEC score of 6 was associated
with a PPV of 96% and a NPV of 96% for NF, and was thus considered
helpful in both ruling in and ruling out NF. We were unable to
validate the LRINEC score in our study, because CRP is not a
routinely used biochemical test at our institution, and so was
unavailable for most patients. Other smaller studies have
evaluated the accuracy of magnetic resonance imaging in
distinguishing NF from non-necrotizing soft tissue infections.13
However, clinicians are unlikely to make surgical decisions
based on simple biochemistry and hematology laboratory results,
and MRI scans are generally discouraged as part of the diagnostic
evaluation process because they can delay deﬁnitive surgical
intervention.4 Therefore, we have sought to generate a simple
clinical prediction rule, based on features of the clinical examina-
tion. This ‘‘PHONES For Surgical Doctor’’ scoring system (Figure 1),
offers a potential means to rule in and/or rule out NF at the bedside,
but requires further validation before being broadly implemented.
Our study has a number of important limitations inherent to its
retrospective design. Under-detection of history and physical
examination ﬁndings is possible due to incomplete chart
documentation, and we had to assume the absence of documen-
tation of a ﬁnding corresponded to absence of that ﬁnding. There
may also have been a potential for ascertainment bias if more
features were examined and documented in the chart once
clinicians became concerned about the possibility of NF. Although
a prospective cohort design would be preferable, it is difﬁcult to
K.A. Alayed et al. / International Journal of Infectious Diseases 36 (2015) 15–2020study NF prospectively because of low recruitment rates for this
rare and severe condition.20 Thus, most NF literature will
inevitably be retrospective in design.5 A spectrum bias may have
been introduced by selecting any cellulitis patients as controls
regardless of severity; however, any attempt to match on a clinical
measure of severity would have precluded an assessment of the
predictive utility of that clinical ﬁnding, and would have obscured
the association of other predictors of NF on history and physical
examination.21 Lastly, some of our predictors of NF, such as
necrosis, are reported to be late ﬁndings on examination.19 Even
though we recorded these signs on initial physical examination
records, they may not be helpful ﬁndings to facilitate early
diagnosis and improved outcomes. Lastly, a larger study with more
NF cases, would enable subgroup analyses for type 1 versus type
2 NF, as well as multivariable modeling to determine the adjusted
association of each history and physical examination characteris-
tic.
5. Conclusions
In summary, we offer the ﬁrst rigorous evaluation of the
diagnostic accuracy of the clinical examination in distinguishing
NF from cellulitis. We conﬁrm the importance of a number of red
ﬂags including pain out of proportion, a report of surgery at the site
of infection in the preceding 90 days, hypotension, diarrhea,
altered mental status, erythema progressing beyond marked
margins, skin ﬂuctuance, hemorrhagic bullae and skin necrosis.
Each of these features had a very strong LR+, and when considered
together, the presence of at least three of these ﬁndings potentially
ruled in NF, whereas the absence of all ﬁndings ruled out this
devastating infection. Further prospective studies, with larger
sample sizes, would be helpful to validate and reﬁne this predictive
rule, to aid in early diagnosis and improved outcomes for patients
with NF.
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